United States · Bill · S
S. 1930 (109th)
Inflammatory Bowel Disease Research Act
Introduced
27 October 2005
Last action
27 October 2005 · Introduced
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S12013-12014)
Sponsors
Sen. Reid, Harry [D-NV], Sen. Cochran, Thad [R-MS], Sen. Johnson, Tim [D-SD], Sen. Dodd, Christopher J. [D-CT], Sen. Feinstein, Dianne [D-CA], Sen. Sarbanes, Paul S. [D-MD], Sen. Lautenberg, Frank R. [D-NJ], Sen. Landrieu, Mary L. [D-LA], Sen. Chambliss, Saxby [R-GA], Sen. Lieberman, Joseph I. [ID-CT], Sen. Stabenow, Debbie [D-MI], Sen. Boxer, Barbara [D-CA], Sen. Reed, Jack [D-RI], Sen. Bingaman, Jeff [D-NM], Sen. Durbin, Richard J. [D-IL], Sen. Hatch, Orrin G. [R-UT], Sen. Menendez, Robert [D-NJ], Sen. Kennedy, Edward M. [D-MA], Sen. Dayton, Mark [D-MN], Sen. Mikulski, Barbara A. [D-MD]
Subjects
Healthcare
Source updated
15 August 2025
Summary
Inflammatory Bowel Disease Research Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand, intensify, and coordinate the Institute's research activities on inflammatory bowel disease, with an emphasis on: (1) genetic research on susceptibility for inflammatory bowel disease; (2) research targeted to increase knowledge about the causes and complications of inflammatory bowel disease in children; (3) animal model research; (4) clinical research; (5) expansion of the Institute's Inflammatory Bowel Disease Centers program with a focus on pediatric research; and (6) other research initiatives identified in specified documents. Requires the Director of the Centers for Disease Control and Prevention (CDC) to prepare a National Inflammatory Bowel Disease Action Plan to: (1) address the burden of inflammatory bowel disease in both adult and pediatric populations; (2) address strategies for determining the prevalence of the disease in the United States and the unique demographic characteristics of the patient community; (3) focus on strategies for increasing awareness about the disease within the general public and the health care community; and (4) address mechanisms designed to prevent the progression of the disease and the development of complications.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
27 October 2005
Introduced
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S12013-12014)
Source: IntroReferral
27 October 2005
Introduced
Sponsor introductory remarks on measure. (CR S12013)
Source: IntroReferral
27 October 2005
Introduced
Introduced in Senate
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 27 October 2005 · Download file
Documents
3 official files
Introduced in Senate (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate (text)
Introduced in Senate · EN · 27 October 2005
Introduced in Senate (PDF)
Introduced in Senate · EN · 27 October 2005
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate
summary · EN · 27 October 2005
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Sen. Reid, Harry [D-NV] · D · Sponsor
- Sen. Cochran, Thad [R-MS] · R · Sponsor
- Sen. Johnson, Tim [D-SD] · D · Cosponsor
- Sen. Dodd, Christopher J. [D-CT] · D · Cosponsor
- Sen. Feinstein, Dianne [D-CA] · D · Cosponsor
- Sen. Sarbanes, Paul S. [D-MD] · D · Cosponsor
- Sen. Lautenberg, Frank R. [D-NJ] · D · Cosponsor
- Sen. Landrieu, Mary L. [D-LA] · D · Cosponsor
- Sen. Chambliss, Saxby [R-GA] · R · Cosponsor
- Sen. Lieberman, Joseph I. [ID-CT] · D · Cosponsor
- Sen. Stabenow, Debbie [D-MI] · D · Cosponsor
- Sen. Boxer, Barbara [D-CA] · D · Cosponsor
- Sen. Reed, Jack [D-RI] · D · Cosponsor
- Sen. Bingaman, Jeff [D-NM] · D · Cosponsor
- Sen. Durbin, Richard J. [D-IL] · D · Cosponsor
- Sen. Hatch, Orrin G. [R-UT] · R · Cosponsor
- Sen. Menendez, Robert [D-NJ] · D · Cosponsor
- Sen. Kennedy, Edward M. [D-MA] · D · Cosponsor
- Sen. Dayton, Mark [D-MN] · D · Cosponsor
- Sen. Mikulski, Barbara A. [D-MD] · D · Cosponsor
- · sshr00 · Standing
Related records
- related to → Inflammatory Bowel Disease Research Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/109th-congress/senate-bill/1930
- Open data entity: https://api.congress.gov/v3/bill/109/s/1930
- us · 109-s-1930 · source updated 15 August 2025